DBV Technologies Announces Publication of Detailed Phase III Trial Results Evaluating Viaskin Peanut as a Novel Treatment for Peanut Allergy in The Journal of the American Medical Association

Press/Media

Period23 Feb 2019

Media coverage

1

Media coverage

  • TitleDBV Technologies Announces Publication of Detailed Phase III Trial Results Evaluating Viaskin Peanut as a Novel Treatment for Peanut Allergy in The Journal of the American Medical Association
    Media name/outletPlus Company Updates (PCU)
    Country/TerritoryUnited States
    Date23/02/19
    PersonsKurt Hirschhorn
View all 1
View less